GloPID-R is a unique international network of major research funding organizations.
Together, we facilitate a rapid and effective response to infectious disease outbreaks.

Our mission

Our Work

Our aim is to invest in research capacity and capabilities to support the rapid initiation of scientific research in case of an outbreak.

Data
Sharing

Discover our work to improve data sharing during public health emergencies.
Read more

Clinical Trial
Networks

Hear from the experts on topics such as social science, data sharing, capacity building, and EARL barriers.
Read more

Ebola
Outbreak

GloPID-R members are reacting to outbreaks occurring throughout the world.
Read more

32 members

Since its creation in 2013, GloPID-R has steadily increased its membership. Today, it consists of 32 members worldwide. The World Health Organization, the Coalition for Epidemic Preparedness Innovations (CEPI) and the European & Developing Countries Clinical Trials Partnership (EDCTP) are also actively engaged in the network.

All members
| News |

Read the latest news on how GloPID-R is investing in infectious disease research and innovation.

Latest news

All news

Living Mapping Review: New iteration brings crucial insights for future COVID-19 research funding as we move to a post-pandemic world

23/03/2022
Researchers and funders around the world rely on the COVID-19 Research Project Tracker and associated Living Mapping Review (LMR) to...
Read more

Upcoming webinar: Response to COVID-19 vaccine in patients with a hematological condition and primary immunodeficiencies

07/03/2022
The second webinar in the ZonMw series ‘Response to COVID-19 vaccine in patients with a hematological condition and primary immunodeficiencies’...
Read more

GloPID-R and UK DHSC organise funders’ roundtable to strengthen the clinical trials ecosystem

11/02/2022
Funders play a critical role in clinical trials, representing a major force in improving trial coordination during global health emergencies....
Read more

Resources

GloPID-R publishes funding opportunities related to infectious diseases and shares its expertise through its publications and webinars.

All resources
Funding opportunities
COVID-19

Swiss National Science Foundation – Switzerland

Read more
Funding opportunities
COVID-19

IMI – EU

Read more
Funding opportunities
COVID-19

Federal Ministry of Education and Research – Germany

Read more